Oleoylethanolamide Supplementation Reduces Inflammation and Oxidative Stress in Obese People: A Clinical Trial
Oleoylethanolamide Supplementation Reduces Inflammation and Oxidative Stress in Obese People: A Clinical Trial
نویسندگان: یاسر خواجه بیشک , لاله پیاهو , علیرضا استاد رحیمی , محمد اصغری جعفرآبادی
کلمات کلیدی: Inflammation
Endocannabinoids
Obesity
Oleoylethanolamide
Oxidative stress
نشریه: 55018 , 8 , 3 , 2018
| نویسنده ثبت کننده مقاله |
لاله پیاهو |
| مرحله جاری مقاله |
تایید نهایی |
| دانشکده/مرکز مربوطه |
مرکز تحقیقات علوم تغذیه |
| کد مقاله |
63793 |
| عنوان فارسی مقاله |
Oleoylethanolamide Supplementation Reduces Inflammation and Oxidative Stress in Obese People: A Clinical Trial |
| عنوان لاتین مقاله |
Oleoylethanolamide Supplementation Reduces Inflammation and Oxidative Stress in Obese People: A Clinical Trial |
| ناشر |
4 |
| آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ |
بلی |
| عنوان نشریه (خارج از لیست فوق) |
|
| نوع مقاله |
Original Article |
| نحوه ایندکس شدن مقاله |
ایندکس شده سطح یک – ISI - Web of Science |
| آدرس لینک مقاله/ همایش در شبکه اینترنت |
|
| Purpose: Obesity as a serious public health problem worldwide, results in the incidence of
many chronic diseases. Obesity has been recognized as a chronic low-grade inflammation
disorder. Altered endocannabinoid system tone is also involved in the pathogenesis of
obesity. The present study aimed to investigate the effects of oleoylethanolamide
supplementation on inflammatory biomarkers and oxidative stress in obese people.
Methods: This randomized, double-blind, placebo-controlled clinical trial was carried out
on 60 healthy obese people in 2016 in Tabriz, Iran. Eligible subjects were randomly divided
into intervention (received daily, two 125 mg OEA capsules) and control groups (the same
amounts of starch) and treated for 8 weeks. Blood samples (5 ml) were taken in fasting state
at the baseline and at the end of the study. The concentrations of MDA and TAS were
measured using a spectrophotometer. A high sensitive-C reactive protein level was
measured by Immunoturbidimetry assay using the commercial kit. IL-6 and TNF-α levels
were assayed by the ELISA method. The differences between groups were assessed by
ANCOVA and statistical significance was determined at p<0.05.
Results: Analysis was done on 56 participants who continued intervention until the end of
the study. A significant decrease in the IL-6 and TNF-α serum concentrations was observed
in the intervention group (p<0.001). Changes in other variables were undetectable (p>0.05).
Conclusion: The use of OEA as a complementary pharmacotherapy agent could be
effective in improving inflammation and oxidative stress in obese people. Future studies are
needed to confirm the obtained results. |
| نام فایل |
تاریخ درج فایل |
اندازه فایل |
دانلود |
| scan0004.jpg | 1397/07/25 | 879211 | دانلود |
| apb-8-479.pdf | 1397/06/13 | 510057 | دانلود |